| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.48, valued at
$96k
|
|
| 11/05/2021 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 7,787 shares
@ $0.718, valued at
$5.6k
|
|
| 05/05/2021 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 9,563 shares
@ $0.567, valued at
$5.4k
|
|
| 12/04/2020 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.74, valued at
$59.2k
|
|
| 11/05/2020 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 4,723 shares
@ $0.561, valued at
$2.6k
|
|
| 08/18/2020 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1, valued at
$5k
|
|
| 07/16/2020 |
4
| Rosenblum Mark J (Exec VP Finance, CFO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 49,955 options to buy
@ $1.32, valued at
$65.9k
|
|
| 03/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2019 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/19/2017 |
3
| Rosenblum Mark J (CEO) has filed a Form 3 on ACTIVECARE, INC. |
| 02/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2014 |
4
| Rosenblum Mark J (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 80,000 shares
@ $0
Paid exercise price by delivering 8,324 shares
@ $4.03, valued at
$33.5k
|
|
| 01/09/2014 |
4
| Rosenblum Mark J (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,985 shares
@ $0
Paid exercise price by delivering 1,565 shares
@ $4.03, valued at
$6.3k
|
|
| 10/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2012 |
4
| Rosenblum Mark J (CFO, SVP and Secretary) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 686,275 shares
@ $0
Disposed/sold convertible notes
@ $0.15, valued at
$0
Disposed/sold 196,078 warrants
@ $0.15, valued at
$29.4k
|
|
| 11/10/2011 |
4
| Rosenblum Mark J (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,100,000 options
@ $0.148, valued at
$310.8k
|
|
| 11/02/2011 |
4
| Rosenblum Mark J (CFO, Senior VP & Secretary) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted convertible notes
@ $0.15, valued at
$0
Granted 196,078 warrants
@ $0.15, valued at
$29.4k
Granted convertible notes
@ $0.15, valued at
$0
Granted 196,078 warrants
@ $0.15, valued at
$29.4k
|
|
| 10/18/2010 |
4
| Rosenblum Mark J (CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 1,200,000 options
@ $0.15, valued at
$180k
|
|
| 01/12/2010 |
3
| Rosenblum Mark J (CFO) has filed a Form 3 on Advaxis, Inc. |
| 03/09/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |